32 related articles for article (PubMed ID: 2787362)
1. For many but not for all: how the conformational flexibility of the peptide/MHCII complex shapes epitope selection.
Ferrante A
Immunol Res; 2013 May; 56(1):85-95. PubMed ID: 22753017
[TBL] [Abstract][Full Text] [Related]
2. HLA Class II Specificity Assessed by High-Density Peptide Microarray Interactions.
Osterbye T; Nielsen M; Dudek NL; Ramarathinam SH; Purcell AW; Schafer-Nielsen C; Buus S
J Immunol; 2020 Jul; 205(1):290-299. PubMed ID: 32482711
[TBL] [Abstract][Full Text] [Related]
3. MHC class II tetramers made from isolated recombinant α and β chains refolded with affinity-tagged peptides.
Braendstrup P; Justesen S; Osterbye T; Nielsen LL; Mallone R; Vindeløv L; Stryhn A; Buus S
PLoS One; 2013; 8(9):e73648. PubMed ID: 24023895
[TBL] [Abstract][Full Text] [Related]
4. Human homologues of a Borrelia T cell epitope associated with antibiotic-refractory Lyme arthritis.
Drouin EE; Glickstein L; Kwok WW; Nepom GT; Steere AC
Mol Immunol; 2008 Jan; 45(1):180-9. PubMed ID: 17555819
[TBL] [Abstract][Full Text] [Related]
5. Copolymer 1 acts against the immunodominant epitope 82-100 of myelin basic protein by T cell receptor antagonism in addition to major histocompatibility complex blocking.
Aharoni R; Teitelbaum D; Arnon R; Sela M
Proc Natl Acad Sci U S A; 1999 Jan; 96(2):634-9. PubMed ID: 9892685
[TBL] [Abstract][Full Text] [Related]
6. Virus and cytotoxic T lymphocytes: crucial role of viral peptide secondary structure in major histocompatibility complex class I interactions.
Gairin JE; Oldstone MB
J Virol; 1993 May; 67(5):2903-7. PubMed ID: 7682632
[TBL] [Abstract][Full Text] [Related]
7. Francisella tularensis--a model for studies of the immune response to intracellular bacteria in man.
Tärnvik A; Eriksson M; Sandström G; Sjöstedt A
Immunology; 1992 Jul; 76(3):349-54. PubMed ID: 1526645
[No Abstract] [Full Text] [Related]
8. [A turning point in the knowledge of the structure-function-activity relations of elastin].
Alix AJ
J Soc Biol; 2001; 195(2):181-93. PubMed ID: 11727705
[TBL] [Abstract][Full Text] [Related]
9. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
Atassi MZ; Oshima M; Deitiker P
Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
[TBL] [Abstract][Full Text] [Related]
10. Effect of conformational propensity of peptide antigens in their interaction with MHC class II molecules. Failure to document the importance of regular secondary structures.
Sette A; Lamont A; Buus S; Colon SM; Miles C; Grey HM
J Immunol; 1989 Aug; 143(4):1268-73. PubMed ID: 2787362
[TBL] [Abstract][Full Text] [Related]
11. The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition.
Boehncke WH; Takeshita T; Pendleton CD; Houghten RA; Sadegh-Nasseri S; Racioppi L; Berzofsky JA; Germain RN
J Immunol; 1993 Jan; 150(2):331-41. PubMed ID: 8093457
[TBL] [Abstract][Full Text] [Related]
12. Nature of the ligand recognized by a hapten- and carrier-specific, MHC-restricted T cell receptor.
Nalefski EA; Rao A
J Immunol; 1993 May; 150(9):3806-16. PubMed ID: 7682584
[TBL] [Abstract][Full Text] [Related]
13. The use of peptide analogs with improved stability and MHC binding capacity to inhibit antigen presentation in vitro and in vivo.
Lamont AG; Powell MF; Colón SM; Miles C; Grey HM; Sette A
J Immunol; 1990 Apr; 144(7):2493-8. PubMed ID: 2319129
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II MHC molecule.
Takeshita T; Takahashi H; Kozlowski S; Ahlers JD; Pendleton CD; Moore RL; Nakagawa Y; Yokomuro K; Fox BS; Margulies DH
J Immunol; 1995 Feb; 154(4):1973-86. PubMed ID: 7530749
[TBL] [Abstract][Full Text] [Related]
15. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.
Gregori S; Trembleau S; Penna G; Gallazzi F; Hammer J; Papadopoulos GK; Adorini L
J Immunol; 1999 Jun; 162(11):6630-40. PubMed ID: 10352280
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
